This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Celgene Quanticel Research, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Diana R Dunshee: Innovator in Leukemia Treatment
Introduction
Diana R Dunshee is a prominent inventor based in Alamo, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of leukemia and myelodysplastic syndrome. Her innovative work has the potential to improve patient outcomes and advance therapeutic strategies.
Latest Patents
Diana holds a patent for her invention titled "Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome." This patent outlines methods for using 5-azacytidine in combination with additional agents to treat diseases and disorders, including acute myeloid leukemia (AML). Her work in this area is crucial for developing more effective treatment options.
Career Highlights
Diana is associated with Celgene Quanticel Research, Inc., where she continues to push the boundaries of medical research. Her dedication to innovation in the pharmaceutical industry has established her as a key figure in her field.
Collaborations
Diana has collaborated with notable colleagues, including C L Beach and Shelonitda Rose. These partnerships have fostered a collaborative environment that enhances the research and development of new therapies.
Conclusion
Diana R Dunshee's contributions to the field of leukemia treatment exemplify the impact of innovative thinking in medicine. Her work not only advances scientific knowledge but also holds promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile